S

SynAct Pharma

7 employees

SynAct Pharma develops drugs for acute deterioration in inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
COVID-19
Melanocortins
Inflammation
Nephrotic Syndrome
Health Care
Rheumatoid Arthritis

Date founded

2013

Funding rounds raised

Total raised

$86K

from 1 investors over 1 rounds

S

SynAct Pharma raised $86K on May 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ